Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Number of Reportable Segments

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Number of Reportable Segments

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Number of Reportable Segments of 3 segment for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfReportableSegments · last filed 2026-08-05

  • 2020-06-27: Number of Reportable Segments 6 month 3.00 numberOfSegments.

numberOfSegments

Period endNumber of Reportable Segments 6 month
2020-06-273.00 numberOfSegments
10-Q · filed 2020-08-05

pure

Period endNumber of Reportable SegmentsNumber of Reportable Segments 12 month
2015-12-26300.00%
10-K · filed 2016-02-12
2014-06-27200.00%
10-K · filed 2016-02-12
2013-12-28200.00%
10-K · filed 2014-02-25

segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-06-273.00 segment
10-Q · filed 2026-08-05
2026-03-283.00 segment
10-Q · filed 2026-05-07
2025-12-273.00 segment
10-K · filed 2026-02-18
2025-09-273.00 segment
10-Q · filed 2025-11-05
2025-06-283.00 segment
10-Q · filed 2025-08-06
2025-03-293.00 segment
10-Q · filed 2025-05-07
2024-12-283.00 segment
10-K · filed 2025-02-19
2024-09-283.00 segment
10-Q · filed 2024-11-06
2024-06-293.00 segment
10-Q · filed 2024-08-07
2024-03-303.00 segment
10-Q · filed 2024-05-09
2023-12-303.00 segment
10-K · filed 2024-02-14
2023-09-303.00 segment
10-Q · filed 2023-11-08
2023-07-013.00 segment
10-Q · filed 2023-08-09
2023-04-013.00 segment
10-Q · filed 2023-05-11
2022-12-313.00 segment
10-K · filed 2023-02-22
2022-09-243.00 segment
10-Q · filed 2022-11-02
2022-06-253.00 segment
10-Q · filed 2022-08-03
2022-03-263.00 segment
10-Q · filed 2022-05-04
2021-12-253.00 segment
10-K · filed 2022-02-16
2021-09-253.00 segment
10-Q · filed 2021-11-03
2021-06-263.00 segment
10-Q · filed 2021-08-04
2021-03-273.00 segment
10-Q · filed 2021-05-04
2020-12-263.00 segment
10-K · filed 2021-02-17
2020-09-263.00 segment
10-Q · filed 2020-10-29

segments

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2020-03-283.00 segments
10-Q · filed 2020-05-07
2019-12-283.00 segments
10-K · filed 2020-02-11
2019-09-283.00 segments
10-Q · filed 2019-11-06
2019-06-293.00 segments
10-Q · filed 2019-07-31
2019-03-303.00 segments
10-Q · filed 2019-05-07
2018-12-293.00 segments
10-K · filed 2019-02-13
2018-09-293.00 segments
10-Q · filed 2018-11-07
2018-06-303.00 segments
10-Q · filed 2018-08-08
2018-03-313.00 segments
10-Q · filed 2018-05-10
2017-12-303.00 segments
10-K · filed 2018-02-13
2017-09-303.00 segments
10-Q · filed 2017-11-09
2016-12-313.00 segments
10-K · filed 2017-02-14
2016-09-243.00 segments
10-Q · filed 2016-11-02
2016-06-253.00 segments
10-Q · filed 2016-08-03
2016-03-263.00 segments
10-Q · filed 2016-05-04
2015-09-263.00 segments
10-Q · filed 2015-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71